A Mixed-method Pilot Investigation of Paradoxical Intention for Insomnia.
Launched by ÖREBRO UNIVERSITY, SWEDEN · Feb 13, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a technique called "paradoxical intention" to help improve sleep for adults suffering from insomnia. Paradoxical intention is a way of treating insomnia that encourages people to try not to sleep, which can surprisingly help reduce anxiety around sleep and improve rest. While previous studies have shown promise for this approach, it hasn't been widely researched in recent years. The aim of this pilot study is to find out how well this technique works, how acceptable it is to patients, and whether it can be easily used in today's context.
To participate, individuals must be at least 18 years old, live in Sweden, and be comfortable speaking the language. They will need to undergo a screening process that includes filling out an online questionnaire, having a structured phone interview, and keeping a sleep diary for a week. Participants should have insomnia symptoms that occur at least three nights a week for three months or longer. However, those with severe depression, certain mental health disorders, or recent changes in sleep medication will not be eligible. This trial is currently not recruiting participants yet, but it's an important step towards understanding new ways to help people get better sleep.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing three screening phases: a web-based questionnaire, a telephone interview with a structured assessment, and a 7-day sleep diary completion.
- • Screening resulting in diagnosis of insomnia, including co-morbid insomnia.
- • Participant should fulfill the following DSM-5 criteria. (1)Difficulty in sleep Initiation, maintenance, or early morning awakening. (2)Frequency and duration of at least three nights per week and has been present for at least three months.(3) Problems persist despite candidates having had adequate opportunity and circumstances for sleep. (4) The sleep disturbance causes significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning.
- • Age above 18 and Swedish resident and language proficient.
- Exclusion Criteria:
- • Severe depressive episode with suicidal intentions or actions
- • Current or past diagnosis of psychotic or bipolar disorders
- • Current substance use disorder
- • Recent changes in psychopharmacotherapy (within the last three months) or use of "as-needed" hypnotic medications during the trial.
About örebro University, Sweden
Örebro University, located in Sweden, is a prominent academic institution dedicated to advancing research and education in various fields, including health sciences. The university actively engages in clinical trials to enhance medical knowledge and improve patient outcomes. With a strong focus on interdisciplinary collaboration, Örebro University fosters innovative research initiatives that align with ethical standards and regulatory requirements. Its commitment to excellence in clinical research is supported by a team of experienced researchers and state-of-the-art facilities, making it a key player in the global medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Stockholm, , Sweden
örebro, , Sweden
örebro, örebro Län, Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported